APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Surfactant

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pulmonary Surfactant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchPulmonary Surfactant Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Surfactant Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Surfactant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Surfactant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Surfactant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pulmonary Surfactant market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pulmonary Surfactant include Abbott, Nanjing Norris Pharm Technology, AbbVie, XpressBio, Windtree Therapeutics, Tekzima (Noargen), Reddot Biotech, ONY Biotech and Lyomark Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pulmonary Surfactant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Surfactant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Surfactant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pulmonary Surfactant market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Surfactant Segment by Company

Abbott

Nanjing Norris Pharm Technology

AbbVie

XpressBio

Windtree Therapeutics

Tekzima (Noargen)

Reddot Biotech

ONY Biotech

Lyomark Pharma

LSBio

Creative Diagnostics

Boehringer Ingelheim

Biorbyt

Biomatik

Aviva Systems Biology

Pulmonary Surfactant Segment by Type

Synthetic Pulmonary Surfactants

Animal Derived Surfactants

Pulmonary Surfactant Segment by Application

Hospital

laboratory

Others

Pulmonary Surfactant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Surfactant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Surfactant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Surfactant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pulmonary Surfactant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Surfactant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pulmonary Surfactant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pulmonary Surfactant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pulmonary Surfactant Industry Trends Table 2. Pulmonary Surfactant Industry Drivers Table 3. Pulmonary Surfactant Industry Opportunities and Challenges Table 4. Pulmonary Surfactant Industry Restraints Table 5. Global Pulmonary Surfactant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pulmonary Surfactant Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pulmonary Surfactant Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pulmonary Surfactant Sales Market Share by Manufacturers Table 9. Global Pulmonary Surfactant Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pulmonary Surfactant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pulmonary Surfactant Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pulmonary Surfactant Manufacturers, Product Type & Application Table 13. Global Pulmonary Surfactant Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pulmonary Surfactant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Synthetic Pulmonary Surfactants Table 17. Major Manufacturers of Animal Derived Surfactants Table 18. Global Pulmonary Surfactant Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 20. Global Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 21. Global Pulmonary Surfactant Sales Market Share by Type (2021-2026) Table 22. Global Pulmonary Surfactant Sales Market Share by Type (2027-2032) Table 23. Global Pulmonary Surfactant Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pulmonary Surfactant Revenue by Type (2021-2026) & (k units) Table 25. Global Pulmonary Surfactant Revenue by Type (2027-2032) & (k units) Table 26. Global Pulmonary Surfactant Revenue Market Share by Type (2021-2026) Table 27. Global Pulmonary Surfactant Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of laboratory Table 30. Major Manufacturers of Others Table 31. Global Pulmonary Surfactant Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 33. Global Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 34. Global Pulmonary Surfactant Sales Market Share by Application (2021-2026) Table 35. Global Pulmonary Surfactant Sales Market Share by Application (2027-2032) Table 36. Global Pulmonary Surfactant Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Pulmonary Surfactant Revenue by Application (2021-2026) & (k units) Table 38. Global Pulmonary Surfactant Revenue by Application (2027-2032) & (k units) Table 39. Global Pulmonary Surfactant Revenue Market Share by Application (2021-2026) Table 40. Global Pulmonary Surfactant Revenue Market Share by Application (2027-2032) Table 41. Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Pulmonary Surfactant Sales by Region (2021-2026) & (k units) Table 43. Global Pulmonary Surfactant Sales Market Share by Region (2021-2026) Table 44. Global Pulmonary Surfactant Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Pulmonary Surfactant Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 48. North America Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 49. Europe Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 51. Europe Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Pulmonary Surfactant Sales by Country (2027-2032) & (k units) Table 58. Global Pulmonary Surfactant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pulmonary Surfactant Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Pulmonary Surfactant Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Pulmonary Surfactant Revenue Market Share by Region (2021-2026) Table 62. Global Pulmonary Surfactant Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Pulmonary Surfactant Product Portfolio Table 67. Abbott Recent Development Table 68. Nanjing Norris Pharm Technology Company Information Table 69. Nanjing Norris Pharm Technology Business Overview Table 70. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio Table 72. Nanjing Norris Pharm Technology Recent Development Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AbbVie Pulmonary Surfactant Product Portfolio Table 77. AbbVie Recent Development Table 78. XpressBio Company Information Table 79. XpressBio Business Overview Table 80. XpressBio Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. XpressBio Pulmonary Surfactant Product Portfolio Table 82. XpressBio Recent Development Table 83. Windtree Therapeutics Company Information Table 84. Windtree Therapeutics Business Overview Table 85. Windtree Therapeutics Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Windtree Therapeutics Pulmonary Surfactant Product Portfolio Table 87. Windtree Therapeutics Recent Development Table 88. Tekzima (Noargen) Company Information Table 89. Tekzima (Noargen) Business Overview Table 90. Tekzima (Noargen) Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Tekzima (Noargen) Pulmonary Surfactant Product Portfolio Table 92. Tekzima (Noargen) Recent Development Table 93. Reddot Biotech Company Information Table 94. Reddot Biotech Business Overview Table 95. Reddot Biotech Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Reddot Biotech Pulmonary Surfactant Product Portfolio Table 97. Reddot Biotech Recent Development Table 98. ONY Biotech Company Information Table 99. ONY Biotech Business Overview Table 100. ONY Biotech Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. ONY Biotech Pulmonary Surfactant Product Portfolio Table 102. ONY Biotech Recent Development Table 103. Lyomark Pharma Company Information Table 104. Lyomark Pharma Business Overview Table 105. Lyomark Pharma Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lyomark Pharma Pulmonary Surfactant Product Portfolio Table 107. Lyomark Pharma Recent Development Table 108. LSBio Company Information Table 109. LSBio Business Overview Table 110. LSBio Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. LSBio Pulmonary Surfactant Product Portfolio Table 112. LSBio Recent Development Table 113. Creative Diagnostics Company Information Table 114. Creative Diagnostics Business Overview Table 115. Creative Diagnostics Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Creative Diagnostics Pulmonary Surfactant Product Portfolio Table 117. Creative Diagnostics Recent Development Table 118. Boehringer Ingelheim Company Information Table 119. Boehringer Ingelheim Business Overview Table 120. Boehringer Ingelheim Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim Pulmonary Surfactant Product Portfolio Table 122. Boehringer Ingelheim Recent Development Table 123. Biorbyt Company Information Table 124. Biorbyt Business Overview Table 125. Biorbyt Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Biorbyt Pulmonary Surfactant Product Portfolio Table 127. Biorbyt Recent Development Table 128. Biomatik Company Information Table 129. Biomatik Business Overview Table 130. Biomatik Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Biomatik Pulmonary Surfactant Product Portfolio Table 132. Biomatik Recent Development Table 133. Aviva Systems Biology Company Information Table 134. Aviva Systems Biology Business Overview Table 135. Aviva Systems Biology Pulmonary Surfactant Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Aviva Systems Biology Pulmonary Surfactant Product Portfolio Table 137. Aviva Systems Biology Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Pulmonary Surfactant Distributors List Table 141. Pulmonary Surfactant Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Pulmonary Surfactant Product Image Figure 2. Global Pulmonary Surfactant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Surfactant Market Size (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Surfactant Sales (2021-2032) & (k units) Figure 5. Global Pulmonary Surfactant Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pulmonary Surfactant Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Synthetic Pulmonary Surfactants Image Figure 9. Animal Derived Surfactants Image Figure 10. Global Pulmonary Surfactant Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pulmonary Surfactant Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pulmonary Surfactant Sales Market Share by Type (2021-2032) Figure 13. Global Pulmonary Surfactant Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pulmonary Surfactant Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pulmonary Surfactant Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. laboratory Image Figure 18. Others Image Figure 19. Global Pulmonary Surfactant Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Pulmonary Surfactant Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Pulmonary Surfactant Sales Market Share by Application (2021-2032) Figure 22. Global Pulmonary Surfactant Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pulmonary Surfactant Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Pulmonary Surfactant Revenue Market Share by Application (2021-2032) Figure 25. North America Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 27. U.S. Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 32. Germany Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 39. China Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pulmonary Surfactant Sales Market Share by Country (2021-2032) Figure 47. Brazil Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Pulmonary Surfactant Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Pulmonary Surfactant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Pulmonary Surfactant Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Figure 58. North America Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Figure 60. Europe Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Pulmonary Surfactant Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pulmonary Surfactant Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Pulmonary Surfactant Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Synthetic Pulmonary Surfactants
  • Animal Derived Surfactants
Applications
  • Hospital
  • laboratory
  • Others
Companies covered
  • Abbott
  • Nanjing Norris Pharm Technology
  • AbbVie
  • XpressBio
  • Windtree Therapeutics
  • Tekzima (Noargen)
  • Reddot Biotech
  • ONY Biotech
  • Lyomark Pharma
  • LSBio
  • Creative Diagnostics
  • Boehringer Ingelheim
  • Biorbyt
  • Biomatik
  • Aviva Systems Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pulmonary Surfactant Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pulmonary Surfactant Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pulmonary Surfactant Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pulmonary Surfactant Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pulmonary Surfactant Market Dynamics
  1. 2.1 Pulmonary Surfactant Industry Trends
  2. 2.2 Pulmonary Surfactant Industry Drivers
  3. 2.3 Pulmonary Surfactant Industry Opportunities and Challenges
  4. 2.4 Pulmonary Surfactant Industry Restraints
3 Pulmonary Surfactant Market by Manufacturers
  1. 3.1 Global Pulmonary Surfactant Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pulmonary Surfactant Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pulmonary Surfactant Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pulmonary Surfactant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pulmonary Surfactant Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pulmonary Surfactant Manufacturers, Product Type & Application
  7. 3.7 Global Pulmonary Surfactant Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pulmonary Surfactant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pulmonary Surfactant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pulmonary Surfactant Tier 1, Tier 2, and Tier 3
4 Pulmonary Surfactant Market by Type
  1. 4.1 Pulmonary Surfactant Type Introduction
  2. 4.1.1 Synthetic Pulmonary Surfactants
  3. 4.1.2 Animal Derived Surfactants
  4. 4.2 Global Pulmonary Surfactant Sales by Type
  5. 4.2.1 Global Pulmonary Surfactant Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pulmonary Surfactant Sales by Type (2021-2032)
  7. 4.2.3 Global Pulmonary Surfactant Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pulmonary Surfactant Revenue by Type
  9. 4.3.1 Global Pulmonary Surfactant Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pulmonary Surfactant Revenue by Type (2021-2032)
  11. 4.3.3 Global Pulmonary Surfactant Revenue Market Share by Type (2021-2032)
5 Pulmonary Surfactant Market by Application
  1. 5.1 Pulmonary Surfactant Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 laboratory
  4. 5.1.3 Others
  5. 5.2 Global Pulmonary Surfactant Sales by Application
  6. 5.2.1 Global Pulmonary Surfactant Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Surfactant Sales by Application (2021-2032)
  8. 5.2.3 Global Pulmonary Surfactant Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pulmonary Surfactant Revenue by Application
  10. 5.3.1 Global Pulmonary Surfactant Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pulmonary Surfactant Revenue by Application (2021-2032)
  12. 5.3.3 Global Pulmonary Surfactant Revenue Market Share by Application (2021-2032)
6 Global Pulmonary Surfactant Sales by Region
  1. 6.1 Global Pulmonary Surfactant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pulmonary Surfactant Sales by Region (2021-2032)
  3. 6.2.1 Global Pulmonary Surfactant Sales by Region (2021-2026)
  4. 6.2.2 Global Pulmonary Surfactant Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pulmonary Surfactant Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pulmonary Surfactant Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pulmonary Surfactant Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pulmonary Surfactant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pulmonary Surfactant Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pulmonary Surfactant Revenue by Region
  1. 7.1 Global Pulmonary Surfactant Revenue by Region
  2. 7.1.1 Global Pulmonary Surfactant Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pulmonary Surfactant Revenue by Region (2021-2026)
  4. 7.1.3 Global Pulmonary Surfactant Revenue by Region (2027-2032)
  5. 7.1.4 Global Pulmonary Surfactant Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pulmonary Surfactant Revenue (2021-2032)
  8. 7.2.2 North America Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pulmonary Surfactant Revenue (2021-2032)
  11. 7.3.2 Europe Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pulmonary Surfactant Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pulmonary Surfactant Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pulmonary Surfactant Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Pulmonary Surfactant Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Nanjing Norris Pharm Technology
  8. 8.2.1 Nanjing Norris Pharm Technology Company Information
  9. 8.2.2 Nanjing Norris Pharm Technology Business Overview
  10. 8.2.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
  12. 8.2.5 Nanjing Norris Pharm Technology Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie Pulmonary Surfactant Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 XpressBio
  20. 8.4.1 XpressBio Company Information
  21. 8.4.2 XpressBio Business Overview
  22. 8.4.3 XpressBio Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 XpressBio Pulmonary Surfactant Product Portfolio
  24. 8.4.5 XpressBio Recent Developments
  25. 8.5 Windtree Therapeutics
  26. 8.5.1 Windtree Therapeutics Company Information
  27. 8.5.2 Windtree Therapeutics Business Overview
  28. 8.5.3 Windtree Therapeutics Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio
  30. 8.5.5 Windtree Therapeutics Recent Developments
  31. 8.6 Tekzima (Noargen)
  32. 8.6.1 Tekzima (Noargen) Company Information
  33. 8.6.2 Tekzima (Noargen) Business Overview
  34. 8.6.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
  36. 8.6.5 Tekzima (Noargen) Recent Developments
  37. 8.7 Reddot Biotech
  38. 8.7.1 Reddot Biotech Company Information
  39. 8.7.2 Reddot Biotech Business Overview
  40. 8.7.3 Reddot Biotech Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Reddot Biotech Pulmonary Surfactant Product Portfolio
  42. 8.7.5 Reddot Biotech Recent Developments
  43. 8.8 ONY Biotech
  44. 8.8.1 ONY Biotech Company Information
  45. 8.8.2 ONY Biotech Business Overview
  46. 8.8.3 ONY Biotech Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ONY Biotech Pulmonary Surfactant Product Portfolio
  48. 8.8.5 ONY Biotech Recent Developments
  49. 8.9 Lyomark Pharma
  50. 8.9.1 Lyomark Pharma Company Information
  51. 8.9.2 Lyomark Pharma Business Overview
  52. 8.9.3 Lyomark Pharma Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio
  54. 8.9.5 Lyomark Pharma Recent Developments
  55. 8.10 LSBio
  56. 8.10.1 LSBio Company Information
  57. 8.10.2 LSBio Business Overview
  58. 8.10.3 LSBio Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LSBio Pulmonary Surfactant Product Portfolio
  60. 8.10.5 LSBio Recent Developments
  61. 8.11 Creative Diagnostics
  62. 8.11.1 Creative Diagnostics Company Information
  63. 8.11.2 Creative Diagnostics Business Overview
  64. 8.11.3 Creative Diagnostics Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio
  66. 8.11.5 Creative Diagnostics Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
  73. 8.13 Biorbyt
  74. 8.13.1 Biorbyt Company Information
  75. 8.13.2 Biorbyt Business Overview
  76. 8.13.3 Biorbyt Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biorbyt Pulmonary Surfactant Product Portfolio
  78. 8.13.5 Biorbyt Recent Developments
  79. 8.14 Biomatik
  80. 8.14.1 Biomatik Company Information
  81. 8.14.2 Biomatik Business Overview
  82. 8.14.3 Biomatik Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biomatik Pulmonary Surfactant Product Portfolio
  84. 8.14.5 Biomatik Recent Developments
  85. 8.15 Aviva Systems Biology
  86. 8.15.1 Aviva Systems Biology Company Information
  87. 8.15.2 Aviva Systems Biology Business Overview
  88. 8.15.3 Aviva Systems Biology Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio
  90. 8.15.5 Aviva Systems Biology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pulmonary Surfactant Value Chain Analysis
  2. 9.1.1 Pulmonary Surfactant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pulmonary Surfactant Production Mode & Process
  6. 9.2 Pulmonary Surfactant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pulmonary Surfactant Distributors
  9. 9.2.3 Pulmonary Surfactant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst